Phenytoin Dosing for Average Adults
For an average adult without hepatic or cardiac disease, administer phenytoin 18-20 mg/kg as a loading dose, followed by maintenance dosing of 300 mg daily (typically divided as 100 mg three times daily initially, with potential consolidation to once-daily dosing once seizure control is established). 1
Loading Dose Administration
For acute seizure control or status epilepticus:
- Loading dose: 18-20 mg/kg IV 2
- Infusion rate: 50 mg/min maximum for patients ≤50 years without atherosclerotic cardiovascular disease (ASCVD) 3
- Reduce to 25 mg/min for patients >50 years or with any history of ASCVD, as this population demonstrates significantly more cardiovascular side effects (hypotension and bradycardia) 3
Alternative Loading Strategy
For oral loading when IV administration is not desirable (clinic/hospital setting with close monitoring only):
- Day 1: 1000 mg total divided as 400 mg, 300 mg, 300 mg at 2-hour intervals 1
- Begin maintenance dosing 24 hours after loading dose
- This achieves therapeutic levels (10-20 mcg/mL) within 5-30 minutes and maintains them in most patients 4
Maintenance Dosing
Standard maintenance: 300 mg daily 1
Initial Dosing Strategy
- Start with 100 mg three times daily (divided dosing)
- Adjust based on clinical response and serum levels
- May increase up to 200 mg three times daily if needed 1
Once-Daily Consolidation
- After seizure control is established with 300 mg daily in divided doses, consolidate to 300 mg once daily 1
- This improves compliance and is appropriate for institutionalized patients or those with adherence challenges
- Only use extended phenytoin sodium capsules (Dilantin) for once-daily dosing—other formulations have different dissolution characteristics that preclude this approach 1
Critical Monitoring Points
Therapeutic serum level target: 10-20 mcg/mL 2, 1
Timing Considerations
- Allow 7-10 days to reach steady-state before making dosage adjustments 1
- Changes made more frequently than every 7-10 days risk overshooting or undershooting therapeutic targets due to phenytoin's nonlinear (Michaelis-Menten) kinetics
When to Check Levels
- After loading dose (2 hours post-infusion for IV) 5
- At steady state (7-10 days after any dose change) 1
- When switching between formulations or brands 1
- If seizure control is inadequate or toxicity is suspected
Important Caveats
Formulation matters critically:
- Extended phenytoin sodium capsules contain ~8% more drug than free acid formulations (suspension, chewable tablets)
- Always monitor serum levels when switching between formulations 1
- Different manufacturers' products may have different bioavailability—brand changes require monitoring
The 300 mg daily dose is often insufficient:
- 85.6% of patients fail to achieve therapeutic concentrations (10-20 mcg/mL) on 300 mg daily 6
- Weight-based dosing (4-8 mg/kg for maintenance) provides better initial estimates 1
- Individual pharmacokinetic variability (Vmax and Km) necessitates dose titration based on serum levels 6
Phenytoin has significant limitations:
- Only 56% success rate in terminating status epilepticus even after benzodiazepines 2
- Numerous adverse effects: hypotension, cardiac dysrhythmias, soft tissue injury with extravasation, purple glove syndrome 2
- Consider alternatives (valproate, levetiracetam) which may be equally or more effective with fewer adverse effects 2